Qiagen N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
05 mei 2015 - 22:08
Statutaire naam
Qiagen N.V.
Titel
QIAGEN reports results for first quarter 2015
Bericht
• Q1 2015 results: Adjusted net sales of $298.7 million (+2% CER); adjusted operating income of $67.4 million; and adjusted EPS of $0.22 ($0.24 CER)
o Adjusted net sales rise 8% CER excluding reduced HPV sales in U.S.
o Investments transforming QIAGEN and strengthening expansion
o Free cash flow rises 40% to $39.7 million
• QIAGEN reaffirms expectations for higher 2015 CER adjusted net sales and earnings; expect adverse impact on reported results from currency movements
Gerelateerde downloads
Datum laatste update: 27 juli 2024